New Markets
Sunday, 7/5, 07:37 PM
Guardant Health Jumps Nearly 20% After UnitedHealth Backs Its Shield Cancer Blood Test
- Shares of Guardant Health rose nearly 20% over the week after UnitedHealth, the largest US health insurer, agreed to cover the company's Shield blood test for colorectal cancer screening.
- The move puts a simple blood draw on a firmer footing against the colonoscopy, though the test has a notable blind spot.